Asset Management
Compare Stocks
2 / 10Stock Comparison
IVZ vs TROW
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
IVZ vs TROW — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Asset Management | Asset Management |
| Market Cap | $12.15B | $23.09B |
| Revenue (TTM) | $6.38B | $7.31B |
| Net Income (TTM) | $-243M | $2.09B |
| Gross Margin | 43.2% | 62.7% |
| Operating Margin | -10.9% | 29.9% |
| Forward P/E | 10.6x | 11.5x |
| Total Debt | $10.12B | $860M |
| Cash & Equiv. | $1.98B | $3.38B |
IVZ vs TROW — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Invesco Ltd. (IVZ) | 100 | 343.2 | +243.2% |
| T. Rowe Price Group… (TROW) | 100 | 87.8 | -12.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IVZ vs TROW
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IVZ is the clearest fit if your priority is growth exposure.
- Rev growth 5.1%, EPS growth -235.6%
- 5.1% NII/revenue growth vs TROW's 3.1%
- Lower P/E (10.6x vs 11.5x)
TROW carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 3 yrs, beta 1.18, yield 4.8%
- 96.8% 10Y total return vs IVZ's 23.3%
- Lower volatility, beta 1.18, Low D/E 7.1%, current ratio 73.08x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.1% NII/revenue growth vs TROW's 3.1% | |
| Value | Lower P/E (10.6x vs 11.5x) | |
| Quality / Margins | Efficiency ratio 0.3% vs IVZ's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 1.18 vs IVZ's 1.67, lower leverage | |
| Dividends | 4.8% yield, 3-year raise streak, vs IVZ's 3.0% | |
| Momentum (1Y) | +98.8% vs TROW's +23.4% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs IVZ's 0.5% |
IVZ vs TROW — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
IVZ vs TROW — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
TROW leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
TROW and IVZ operate at a comparable scale, with $7.3B and $6.4B in trailing revenue. TROW is the more profitable business, keeping 28.5% of every revenue dollar as net income compared to IVZ's -4.4%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $6.4B | $7.3B |
| EBITDAEarnings before interest/tax | $1.2B | $2.7B |
| Net IncomeAfter-tax profit | -$243M | $2.1B |
| Free Cash FlowCash after capex | $1.9B | $2.3B |
| Gross MarginGross profit ÷ Revenue | +43.2% | +62.7% |
| Operating MarginEBIT ÷ Revenue | -10.9% | +29.9% |
| Net MarginNet income ÷ Revenue | -4.4% | +28.5% |
| FCF MarginFCF ÷ Revenue | +22.6% | +20.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +34.2% | +3.7% |
Valuation Metrics
IVZ leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, TROW's 7.9x EV/EBITDA is more attractive than IVZ's 16.5x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $12.2B | $23.1B |
| Enterprise ValueMkt cap + debt − cash | $20.3B | $20.6B |
| Trailing P/EPrice ÷ TTM EPS | -17.09x | 11.47x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.64x | 11.49x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 16.53x | 7.85x |
| Price / SalesMarket cap ÷ Revenue | 1.91x | 3.16x |
| Price / BookPrice ÷ Book value/share | 0.95x | 1.97x |
| Price / FCFMarket cap ÷ FCF | 8.43x | 15.61x |
Profitability & Efficiency
TROW leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
TROW delivers a 17.6% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-2 for IVZ. TROW carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to IVZ's 0.78x. On the Piotroski fundamental quality scale (0–9), IVZ scores 6/9 vs TROW's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -1.7% | +17.6% |
| ROA (TTM)Return on assets | -0.9% | +14.4% |
| ROICReturn on invested capital | -2.3% | +13.3% |
| ROCEReturn on capital employed | -2.6% | +15.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.78x | 0.07x |
| Net DebtTotal debt minus cash | $8.1B | -$2.5B |
| Cash & Equiv.Liquid assets | $2.0B | $3.4B |
| Total DebtShort + long-term debt | $10.1B | $860M |
| Interest CoverageEBIT ÷ Interest expense | -6.19x | — |
Total Returns (Dividends Reinvested)
IVZ leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IVZ five years ago would be worth $11,058 today (with dividends reinvested), compared to $7,079 for TROW. Over the past 12 months, IVZ leads with a +98.8% total return vs TROW's +23.4%. The 3-year compound annual growth rate (CAGR) favors IVZ at 22.3% vs TROW's 4.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +2.3% | +2.7% |
| 1-Year ReturnPast 12 months | +98.8% | +23.4% |
| 3-Year ReturnCumulative with dividends | +83.0% | +13.9% |
| 5-Year ReturnCumulative with dividends | +10.6% | -29.2% |
| 10-Year ReturnCumulative with dividends | +23.3% | +96.8% |
| CAGR (3Y)Annualised 3-year return | +22.3% | +4.4% |
Risk & Volatility
Evenly matched — IVZ and TROW each lead in 1 of 2 comparable metrics.
Risk & Volatility
TROW is the less volatile stock with a 1.18 beta — it tends to amplify market swings less than IVZ's 1.67 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.67x | 1.18x |
| 52-Week HighHighest price in past year | $29.61 | $118.22 |
| 52-Week LowLowest price in past year | $14.04 | $85.51 |
| % of 52W HighCurrent price vs 52-week peak | +92.4% | +89.8% |
| RSI (14)Momentum oscillator 0–100 | 66.3 | 74.8 |
| Avg Volume (50D)Average daily shares traded | 5.1M | 2.3M |
Analyst Outlook
Evenly matched — IVZ and TROW each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates IVZ as "Hold" and TROW as "Hold". Consensus price targets imply 8.7% upside for IVZ (target: $30) vs -4.6% for TROW (target: $101). For income investors, TROW offers the higher dividend yield at 4.81% vs IVZ's 3.04%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $29.72 | $101.20 |
| # AnalystsCovering analysts | 28 | 38 |
| Dividend YieldAnnual dividend ÷ price | +3.0% | +4.8% |
| Dividend StreakConsecutive years of raises | 4 | 3 |
| Dividend / ShareAnnual DPS | $0.83 | $5.11 |
| Buyback YieldShare repurchases ÷ mkt cap | +15.3% | +2.7% |
TROW leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). IVZ leads in 2 (Valuation Metrics, Total Returns). 2 tied.
IVZ vs TROW: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is IVZ or TROW a better buy right now?
For growth investors, Invesco Ltd.
(IVZ) is the stronger pick with 5. 1% revenue growth year-over-year, versus 3. 1% for T. Rowe Price Group, Inc. (TROW). T. Rowe Price Group, Inc. (TROW) offers the better valuation at 11. 5x trailing P/E (11. 5x forward), making it the more compelling value choice. Analysts rate Invesco Ltd. (IVZ) a "Hold" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IVZ or TROW?
On forward P/E, Invesco Ltd.
is actually cheaper at 10. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — IVZ or TROW?
Over the past 5 years, Invesco Ltd.
(IVZ) delivered a total return of +10. 6%, compared to -29. 2% for T. Rowe Price Group, Inc. (TROW). Over 10 years, the gap is even starker: TROW returned +96. 8% versus IVZ's +23. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IVZ or TROW?
By beta (market sensitivity over 5 years), T.
Rowe Price Group, Inc. (TROW) is the lower-risk stock at 1. 18β versus Invesco Ltd. 's 1. 67β — meaning IVZ is approximately 42% more volatile than TROW relative to the S&P 500. On balance sheet safety, T. Rowe Price Group, Inc. (TROW) carries a lower debt/equity ratio of 7% versus 78% for Invesco Ltd. — giving it more financial flexibility in a downturn.
05Which is growing faster — IVZ or TROW?
By revenue growth (latest reported year), Invesco Ltd.
(IVZ) is pulling ahead at 5. 1% versus 3. 1% for T. Rowe Price Group, Inc. (TROW). On earnings-per-share growth, the picture is similar: T. Rowe Price Group, Inc. grew EPS 1. 1% year-over-year, compared to -235. 6% for Invesco Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IVZ or TROW?
T.
Rowe Price Group, Inc. (TROW) is the more profitable company, earning 28. 5% net margin versus -4. 4% for Invesco Ltd. — meaning it keeps 28. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TROW leads at 29. 9% versus -10. 9% for IVZ. At the gross margin level — before operating expenses — TROW leads at 62. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IVZ or TROW more undervalued right now?
On forward earnings alone, Invesco Ltd.
(IVZ) trades at 10. 6x forward P/E versus 11. 5x for T. Rowe Price Group, Inc. — 0. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IVZ: 8. 7% to $29. 72.
08Which pays a better dividend — IVZ or TROW?
All stocks in this comparison pay dividends.
T. Rowe Price Group, Inc. (TROW) offers the highest yield at 4. 8%, versus 3. 0% for Invesco Ltd. (IVZ).
09Is IVZ or TROW better for a retirement portfolio?
For long-horizon retirement investors, T.
Rowe Price Group, Inc. (TROW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 18), 4. 8% yield). Invesco Ltd. (IVZ) carries a higher beta of 1. 67 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TROW: +96. 8%, IVZ: +23. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IVZ and TROW?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: IVZ is a mid-cap income-oriented stock; TROW is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.